Updated September 29 at 1:29pm
Biotechnology
42 results total, viewing 1 - 10
In an effort to support health care technology innovators in the Boston-Cambridge area of Massachusetts, Ximedica has partnered with Cambridge MedSpace, the medical technologies firm said this week. more
The Slater Technology Fund on Monday announced it is committing another $250,000 to the biomedical company ProThera Biologics, bringing Slater’s total investment in the company to $950,000. more
EpiVax Inc. has received a $600,000 grant from the National Institutes of Health through the Small Business Innovation Research program to improve a vaccine for the H7N9 avian influenza virus. more
Economic activity is increasing, but there are some signs of slowing growth, according to the Federal Reserve’s Beige Book report released Wednesday. more
A top pharmaceutical lobbying group is launching an ad campaign to defend drugmakers that have been under fire for their pricing practices. more
Tivorsan Pharmaceuticals Inc. has received orphan drug designation from the U.S. Food and Drug Administration for a drug used in the treatment of Duchenne muscular dystrophy, a genetic disorder characterized by progressive muscle degeneration and weakness. more
Life Wear Technologies LLC has acquired TriCalm’s line of anti-itch products from Cosmederm Bioscience Inc. of San Diego. more
Biotechnology drugmaker AbbVie Inc. filed a lawsuit seeking to block Amgen Inc. from selling a copy of the arthritis medicine Humira, its top seller. more
A Chinese drug manufacturer is investing $42 million in Nabsys, which recently completed a financial restructuring that allowed it to reopen in March after being out of business for nearly seven months. more
IlluminOss Medical Inc. said Monday that it has completed enrollment in its first U.S. clinical trial toward U.S. Food and Drug Administration approval of its IlluminOss System, a minimally invasive system to repair bone fractures. more
1 | 2 | 3 | 4 | 5 Next »